ClinicalTrials.gg
RecruitingNCT07512739Updated Apr 6, 2026

A Sitting Tai Chi Programme for Chronic Stroke Survivors With Post-stroke Cognitive Impairment

An interventional study of Tai Chi in Stroke and Cognitive Impairment, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-06.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Oct 2025, registered Mar 2026).
  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
176
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Stroke by Chinese University of Hong Kong — 20 open to participants now, 21 under way, none of them phase 3. Stroke · Chinese University of Hong Kong.

Planned enrollment
8th of 41
176 · median 64
Started
2025
with 2 others
No phase
38 of 54
15 open now
Primary completion
2026-05
later than 5 of 20 live
Registered
52nd of 54
by date

Among the 54 studies in Stroke by Chinese University of Hong Kong, this one is the 8th largest by planned enrollment of the 41 interventional ones that give a count, is one of 3 that started in 2025, is one of 38 with no phase, reaches primary completion later than 5 of the 20 other live ones, and was the 52nd registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

20 of the 54 studies in Stroke by Chinese University of Hong Kong are open now, in 4 countries. Recruiting first, the newest first:

14 more — sign in →

By country, each count listing its studies:

All 20 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Stroke by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

Introduction Stroke remains the third leading cause of death and disability combined. Post-stroke cognitive impairment (PSCI) is a common neurological sequela that may affect up to 80% of stroke survivors. Several systematic reviews and studies indicated that Tai Chi benefits patients with mild cognitive impairment, leading to significant improvement in cognitive function.

Our previous study adopted a tailored sitting Tai Chi programme for the rehabilitation of subacute stroke survivors without any cognitive impairment. The results of the randomised controlled trial (RCT) showed that upper limb function, balance control, ADL, depressive symptoms, and QoL were significantly improved compared to the control group. To better understand the usefulness of the sitting Tai Chi programme for chronic stroke survivors with cognitive impairment and how it might affect other rehabilitation outcomes, this study was proposed to examine its feasibility and preliminary effectiveness.

Methods An outcome assessor-blinded RCT will be conducted. Participants will be randomised with a 1:1 allocation ratio to either the intervention group or the waiting list control group. A total number of 88 dyads (176 participants) including 44 stroke survivors and 44 caregivers will be recruited in each group.

For the qualitative part, a purposive sample of 30 stroke survivors with low, medium and high satisfaction scores will be invited.

Intervention Sitting Tai Chi group: Participants in the sitting Tai Chi group will receive 12 weeks of 10-form sitting Tai Chi exercise training with a frequency of three days a week and 40 minutes a day, including 5 minutes warm-up, 30 minutes Tai Chi training, and 5 minutes cool-down. A registered nurse (RN) with experience with Tai Chi training and who participated in our previous study will lead the training session. The RN will receive refresher training in sitting Tai Chi and learn the basics about the condition of PSCI and the characteristics of survivors with PSCI.

Control group: Participants in the control group will receive usual care. That is, regular inpatient treatment and care, without additional rehabilitation treatment. At the end of the intervention follow-up assessment, they will be invited to participate in the sitting Tai Chi exercise led by the same nurse as well.

Assessment and measurement Primary outcomes include cognitive function, upper limb function, balance control, and depressive symptoms. They will be assessed at baseline, eight weeks, and 12 weeks after the commencement of the sitting Tai Chi training by validated scales.

  1. Cognitive function will be measured using the MoCA scale.
  2. Upper limb function will be measured using Fugl-Meyer Test Upper Limb section and Wolf Motor Function Test
  3. Balance control will be measured using the Berg Balance Scale and the Trunk Impairment Scale
  4. Depressive symptoms will be measured by the 15 items Geriatric Depression Scale short form.
  5. The Modified Barthel Index will be used to assess ADL.
  6. QoL will be assessed using the Chinese version of Stroke-Specific Quality of Life Scale.

Feasibility and Acceptability This pilot RCT evaluates the feasibility of the sitting Tai Chi programme. Feasibility is evaluated based on recruitment and retention rates from baseline to follow-up. All participants will be invited to fill in a satisfaction survey with the sitting Tai Chi programme and the usefulness of its components.

Satisfaction A self-developed User Satisfaction Questionnaire (USQ) will be used to assess stroke survivors' satisfaction in terms of usability, acceptability, and applicability.

Adverse events measurements Any unexpected adverse events during the intervention period will be monitored. Semi-structured interview We will conduct semi-structured in-depth interviews using a pre-designed semi-structured interview guide.

Ethical considerations Ethical approval will be applied from the Joint Chinese University of Hong Kong- New Territories East Cluster Clinical Research Ethics Committee and the study hospital's research ethics committee. Written consent will be obtained from the eligible participants.

Data collection, consent, and sample storage A sociodemographic and clinical data sheet will be used to record the corresponding information. The research assistants will screen potentially eligible participants by daily reviewing the medical records of all stroke survivors admitted to the study venues.

Data processing and analysis Statistics analysis will be conducted using the IBM SPSS version 29.0. All primary analyses will be conducted on an intention-to-treat basis. Descriptive statistics will be used. A generalized estimating equations (GEE) model will be employed to compare differential change of each of the primary and secondary outcomes across the study time points between the two groups.

Content analysis will be used to analyse the qualitative data from the participants.

03

Conditions studied

  • Stroke
  • Cognitive Impairment
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for stroke patients:

- Individuals who meet the following criteria will be recruited: i. aged 18 years or above; ii. have been admitted to a hospital with a clinical diagnosis of first or recurrent ischaemic or haemorrhagic stroke, and meet the diagnostic criteria of PSCI (classified according to criteria); iii. in the chronic stage of stroke; iv. score: 19-25 (two points are added if the individual has ≤ 6 years of education; one point is added if the individual has > 6 and ≤ 12 years of education, no points are added for the individual with > 12 years of education); v. be able to sit independently with or without sitters; vi. be able to use and raise at least one arm while sitting (upper extremity muscle strength ≥ Ⅲ); vii. have a primary caregiver (a paid or unpaid person who provides most assistance to the stroke survivor); viii. be able to communicate in Chinese and provide ; ix. is currently hospitalised in this geriatric rehabilitation ward and unlikely to be discharged within 3 months.

Exclusion Criteria for stroke patients:

  • Individuals will be excluded if other causes of cognitive impairment are present, such as Alzheimer's disease, acquired immune deficiency syndrome, a National Institutes of Health Stroke Scale (NIHSS) score >16, severe hearing or visual impairment, severe complications following a stroke (e.g., limited comprehension and receptive aphasia, venous thrombosis), a history of severe medical conditions or current serious illnesses (e.g. myocardial infarction, use of a cardiac pacemaker or a defibrillator, organ failure, , mental diseases, other neurological diseases such as multiple sclerosis or Parkinson's disease, having received thrombolytic therapy or surgery, joint replacement surgeries or fractures within the past six months), pregnant or lactating women; prior regular (at least three times/week) Tai Chi practice or other mind-body exercises (e.g., Yoga, Qigong, Ba Duanjin, or mindfulness training) within the past six months; and those participating in other clinical trials that might influence this study.

Inclusion criteria for caregivers:

i. age ≥ 18 years; ii. be able to communicate in Chinese and provide informed consent; iii. medically stable and physically able to provide support.

Exclusion criteria for caregivers:

i. impaired cognitive functions (Abbreviated Mental Test, AMT ≤ 7); ii. being a medical resident/trainee or a physical therapist; iii. having prior regular (at least three times/week) Tai Chi practice or other mind-body exercises (e.g., Yoga, Qigong, Ba Duanjin, or mindfulness training) within the past six months; iv. participating in other clinical trials that might influence affect this study.

Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
176 participants (estimated)

Study arms

  • Experimental
    Sitting Tai Chi group

    Participants in the sitting Tai Chi group will receive 12 weeks of 10-form sitting Tai Chi exercise training with a frequency of three days a week and 40 minutes a day, including 5 minutes warm-up, 30 minutes Tai Chi training, and 5 minutes cool-down. A registered nurse (RN) with experience with Tai Chi training and who participated in our previous study will lead the training session.

    Other: Tai Chi

  • Other
    Control group

    Waiting list control group: Participants in the control group will receive usual care. That is, regular inpatient treatment and care, without additional rehabilitation treatment. At the end of the intervention follow-up assessment, they will be invited to participate in the sitting Tai Chi exercise led by the same nurse as well.

    Other: Tai Chi

Interventions

  • OtherTai Chi

    Five series of sitting Tai Chi exercises for stroke survivors with physical impairments, each with a target of strengthening the muscles for upper limb function and balance while taking into consideration survivors' physical limitations, were developed. Series 1 consisted of a 10-form sitting Tai Chi adapted from the 10-form Yang-style Wheelchair Tai Chi, which was offered for stroke survivors with minor weakness (upper limbs' muscle strength: 4 or 5). Series 2 to 5 were also ready to cater to the needs of stroke survivors with hemiparesis or hemiplegia (upper limbs' muscle strength: ≤3). Caregivers will be involved to ensure the safety of stroke participants, encourage their participation, and supervise them. Adherence to the treatment protocol will be recorded by a research assistant.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in the Mean Cognitive Function at 12 Weeks

    Cognitive function will be measured using the MoCA scale, a cognitive screening instrument developed and validated to detect mild cognitive impairment.

    Time frame: From enrollment to the end of treatment at 12 weeks

  2. Change from Baseline in the Mean Upper Limb Function measured by FMT-UL at 12 Weeks

    Upper limb function will be measured using Fugl-Meyer Test Upper Limb section (FMT-UL). FMT-UL will be used to evaluate upper extremity function. The scale includes eight items related to function of wrist and hand, evaluation results are on a 3-point scale ranging from 0 ('unable accomplish') to 2 ('completely accomplish'), and has a maximum score of 66. A higher score indicates better upper extremity function.

    Time frame: From enrollment to the end of treatment at 12 weeks

  3. Change from Baseline in the Mean Upper Limb Function measured by WMFT at 12 Weeks

    Upper limb function will be measured using Wolf Motor Function Test (WMFT) . The WMFT was often used alongside the FMT-UL to provide a complementary description of upper limb function. It consists of 17 items including time, functional ability and strength domains. Items seven and 14 are strength test with recording the exact weight which the participants can afford.

    Time frame: From enrollment to the end of treatment at 12 weeks

  4. Change from Baseline in the Mean Balance Control measured by BBS at 12 Weeks

    Balance control will be measured using the Berg Balance Scale (BBS). The 14 items BBS will be used to evaluate the ability to maintain positions, from sitting to standing, to close standing, and finally to standing on one leg. The total score ranges from 0 to 56, with a higher score indicates better balance control. The Chinese version of BBS has been reported with good reliability and validity (intra and inter-rater ICC: 0.968-0.985 and 0.992-0.998)

    Time frame: From enrollment to the end of treatment at 12 weeks

  5. Change from Baseline in the Mean Balance Control measured by TIS at 12 Weeks

    Balance control will be measured using the Trunk Impairment Scale (TIS). The Trunk Impairment Scale (TIS) was designed to assess the sitting balance and trunk control among stroke survivors. It has 17 items which consists of three subscales: static sitting balance, dynamic sitting balance and coordination. The total score ranges from zero to 23 points, with a higher score indicating a better performance. It has 17 items which consists of three subscales: static sitting balance, dynamic sitting balance, and coordination.

    Time frame: From enrollment to the end of treatment at 12 weeks

  6. Change from Baseline in the Mean Depressive Symptoms at 12 Weeks

    The 15 items Geriatric Depression Scale short form (GDS-15) will be used to assess depressive symptoms. Each item is scored in a dichotomous format: 1= ('yes'), 0= ('no') in response to symptoms of depression. The total score is summed (range 0-15). A higher score indicates a higher level of depressive symptoms. A score of nine or above indicates moderate or severe depression. The Chinese version of GDS-15 has demonstrated good validity and reliability (Cronbach's α: 0.78) (Chau et al., 2006).

    Time frame: From enrollment to the end of treatment at 12 weeks

Secondary outcomes

  1. Change from Baseline in the Mean Activities of Daily Living at 12 Weeks

    The Modified Barthel Index (MBI) will be used to assess ADL. The scale consists of 10 items to score the ability of a person to care for himself which includes feeding, moving, and toileting. The total scores range from 0 to 100. A higher score suggests better ADL. The psychometric properties of the Chinese version of MBI is good (inter and intra rater ICC: 0.968~0.997 and 0.866~0.990).

    Time frame: From enrollment to the end of treatment at 12 weeks

  2. Change from Baseline in the Mean Quality of Life at 12 Weeks

    QoL will be assessed using the Chinese version of Stroke-Specific Quality of Life Scale SS-QOL. The scale is specific to the activity and participation domains of the ICF. It includes 12 areas affected following a stroke, as covered by 49 items. For each item, there are five response options in which the score varies from one to five. Thus, the overall scores range from 49 (worst perception of QoL) to 245 (best perception of QoL). Higher scores indicate better QoL. The Chinese version of SS-QOL has been reported with acceptable validity and good reliability (Cronbach's α 0.93) (Lo et al., 2017).

    Time frame: From enrollment to the end of treatment at 12 weeks

07

Study locations

1 of 1 sites recruiting
  • The Second People's Hospital of Kunming
    Kunming, Yunnan 650000, China
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — The data could be shared basing on reasonable request.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for May 2026, 7 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 7 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 16, 2026
First posted
Apr 6, 2026
StartActual
Oct 20, 2025
Primary completionEst.
May 31, 2026
CompletionEst.
Aug 31, 2026
Last update
Apr 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07512739
Responsible party
ZHAO Jie (Principal Investigator, Chinese University of Hong Kong) — Principal investigator
First posted
Apr 6, 2026
Start date
Oct 20, 2025
Primary completion
May 31, 2026 (estimated)
Completion
Aug 31, 2026 (estimated)
Last update
Apr 6, 2026

Study contacts

Jie Zhao Dr., PhD
Contact
ZhaoJie@link.cuhk.edu.hk
85239437936

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion